| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 141.44B | 136.93B | 132.65B | 128.29B | 116.26B | 105.81B |
| Gross Profit | 52.77B | 48.15B | 44.50B | 42.45B | 44.04B | 40.11B |
| EBITDA | 29.23B | 27.45B | 25.92B | 26.45B | 28.84B | 25.63B |
| Net Income | 18.20B | 16.89B | 15.99B | 16.66B | 18.30B | 17.04B |
Balance Sheet | ||||||
| Total Assets | 161.31B | 162.78B | 149.32B | 136.32B | 125.68B | 113.24B |
| Cash, Cash Equivalents and Short-Term Investments | 81.97B | 80.38B | 68.19B | 62.64B | 64.28B | 57.81B |
| Total Debt | 1.67B | 1.81B | 1.93B | 2.06B | 2.20B | 2.33B |
| Total Liabilities | 26.82B | 27.48B | 23.89B | 22.08B | 22.12B | 22.65B |
| Stockholders Equity | 134.49B | 135.30B | 125.43B | 114.24B | 103.56B | 90.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 18.57B | 11.52B | 4.51B | 12.07B | 17.16B |
| Operating Cash Flow | 0.00 | 24.79B | 15.23B | 8.81B | 18.45B | 21.32B |
| Investing Cash Flow | 0.00 | -29.93B | -9.00B | 230.00M | -9.63B | -4.54B |
| Financing Cash Flow | 0.00 | -5.67B | -5.68B | -5.68B | -5.35B | -4.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥658.05B | 14.02 | 12.11% | 2.68% | 1.73% | 2.18% | |
77 Outperform | ¥22.91T | 40.16 | 19.84% | 0.90% | 11.25% | 16.84% | |
74 Outperform | ¥584.33B | 19.71 | ― | 1.04% | 14.57% | 25.08% | |
73 Outperform | ¥720.83B | 17.77 | 8.48% | 2.02% | 5.20% | 6.54% | |
68 Neutral | ¥8.24B | 13.03 | ― | 0.51% | 17.43% | 57.55% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
42 Neutral | ¥6.74B | -1.07 | ― | ― | -11.65% | -43.31% |